U.S. Stem Cell
is a Florida-based biotechnology company that develops and markets regenerative medicines for patients with degenerative conditions... Read moreU.S. Stem Cell
is a Florida-based biotechnology company that develops and markets regenerative medicines for patients with degenerative conditions... Read more
News
Apr 17, 2023
Owler
U.S. Stem Cell, Inc.: U.S. Stem Cell's employee count had no change from Dec 2019 to Dec 2022
Nov 10, 2022
Owler
U.S. Stem Cell, Inc.: U.S. Stem Cell's revenue changed from $128.75K in Jun 2022 to $85.67K in Sep 2022
Sep 02, 2022
FinanzNachrichten
U.S. Stem Cell: U.S. Stem Cell, Inc.: Court Reports Favorable Judgment in California Stem Cell Case
Mar 09, 2022
MarketScreener
U.S. Stem Cell: U S Stem Cell : Material Event - Form 8-K/A
Mar 09, 2022
U.s. Stem Cell Blog
U.s. Stem Cell Blog Mark Borman appointed Chairman of the Board of USRM
Oct 18, 2021
MarketScreener
U.S. Stem Cell: U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation
Jun 08, 2021
MarketScreener
U.S. Stem Cell: U S Stem Cell : US Stem Cell Inc Reports Legal Appeal Results and Company Direction
Feb 23, 2021
Accesswire
Press Release: U.S. Stem Cell : Northstar Biotech and USRM BOD Members Reinvest in the Company
Feb 02, 2021
Picante Today
U.s. Stem Cell: Update: Patient Access Solutions, Hestia Insight, and US Stem Cell to Form Business Consortium
Sep 30, 2020
MarketScreener
U.s. Stem Cell: U S Stem Cell : Confirms Date for Appeals Court Oral Arguments
U.S. Stem Cell Competitors
1
2
3
4
5
6
7
8
9
10